Preferred Label : tysabri;

UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T129 - Immunologic Factor;

Is substance : O;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3608834/fr/tysabri-natalizumab-sclerose-en-plaques
2025
France
evaluation of the transparency committee
natalizumab
multiple sclerosis, nos
multiple sclerosis
Natalizumab
multiple sclerosis
tysabri

---
https://www.has-sante.fr/portail/jcms/c_2877334/fr/tysabri
2018
false
false
false
France
multiple sclerosis, relapsing-remitting
treatment outcome
natalizumab
evaluation of the transparency committee
tysabri
Natalizumab
Natalizumab

---
https://www.has-sante.fr/portail/jcms/c_2780899/fr/tysabri
2017
false
false
false
France
French
evaluation of the transparency committee
tysabri
Natalizumab

---
Nous contacter.
23/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.